We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002371:SZSENAURA Technology Group Co., Ltd. Analysis

Data as of 2026-08-31 - not real-time

CN¥699.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind NAURA Technology Group Co., Ltd. is neutral at ¥699.79, with no clear ordering between short and long averages. It has gained 3.4% over the past 30 days. RSI sits at 44.8, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near ¥632.01 and resistance around ¥785.90.
On valuation the read is overvalued — earnings multiple of 89.6 versus a 35.6 sector average, above the peer group. Sell-side targets cluster 23.9% above the current quote. Revenue is growing at 24.0% on a 13.1% profit margin. The 0.11% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 64.2%, a beta of 0.21 and a maximum drawdown of 31.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Barron's1yNAURA Technology Group Co. Ltd. ANAURA Technology Group Co., Ltd. engages in the research, development,...Barron's1monNAURA Technology Group Co. Ltd. ANAURA Technology Group Co., Ltd. engages in the research, development,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 562.90
  • MACD momentum is negative
  • 30-day volatility of 64.2%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 89.6 versus sector average of 35.6
  • Trading above the 200-day average of 562.90
  • Analyst targets imply +23.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 89.6 versus sector average of 35.6
  • Analyst targets imply +23.9% versus the current price
  • Revenue growth of +24.0%

Key Metrics & Analysis

Financial Health

Revenue Growth24.00%
Profit Margin13.10%
P/E Ratio89.6
ROE12.53%
ROA4.16%
Debt/Equity29.75
P/B Ratio12.5
Op. Cash FlowCN¥9.1B
Free Cash FlowCN¥6.8B
Industry P/E35.6

Technical Analysis

TrendNeutral
RSI44.8
SupportCN¥632.01
ResistanceCN¥785.90
MA 20CN¥728.31
MA 50CN¥753.12
MA 200CN¥562.90
MACDBearish
VolumeDecreasing
Fear & Greed Index94.36

Valuation

Fair ValueCN¥321.71
Target PriceCN¥867.28
Upside/Downside23.93%
GradeOvervalued
TypeGrowth
Dividend Yield0.11%

Risk Assessment

Beta0.21
Volatility64.20%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.